• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trial Listings
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Market Research
    • Benchmark Reports
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Clinical Trial Listings
  • Advertise
  • COVID-19
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » PharPoint Research named one of Triangle Area’s fastest growing companies for 2016

PharPoint Research named one of Triangle Area’s fastest growing companies for 2016

October 6, 2016
CenterWatch Staff

PharPoint Research, a CRO headquartered in North Carolina, is once again a recipient of the Triangle Business Journal’s Fast 50 award, which highlights 50 of the fastest growing companies in the Triangle area. This is the fourth time the company has received this honor.

Each honoree is selected and ranked based on a formula that counts revenue growth and profitability in the preceding three years (2013 to 2015). The data are processed and analyzed by PricewaterhouseCoopers and the rankings will be revealed during the Fast 50 Awards dinner on November 9.

PharPoint has increased their presence in the pharmaceutical industry over the past 12 months, by now providing clinical development services for global trials. “Our global expertise offers Sponsors access to emerging markets and heightens our management of clinical trials,” said PharPoint CEO, Art Holmes.

The company has evolved into a full-service CRO over the past decade and developed processes to manage trial logistics in a completely virtual environment to improve transparency and information exchange with Sponsors. “Our clients are a testament to our success,” continued Holmes. “Our growth is a direct result of the strong relationships we build with Sponsors and partners alike. Companies turn to PharPoint for our team’s breadth of therapeutic and program expertise, horizontal business structure, and study execution capabilities. We are proud to be recognized by the Triangle Business Journal for our continued level of service to our clients.”

Upcoming Events

  • 06Jun

    Gene & Cell Therapy Regulation: Comparability and Other New Developments

  • 07Jun

    Developing World-Class SOPs: Optimizing Quality and Compliance

  • 08Jun

    Implementing ICH E8 R1 Recommendations Increases Site and Participant Relationship Scoring Measures

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • MAGI East 2023

    MAGI East 2023 Preview: Janssen Reports on Environmental Impact of Trials

  • Complexity-360x240.png

    Phase 3 Trials Significantly Rising in Complexity, Says CSDD

  • Quality Level Scale

    Build Quality into Trials Like You’d Build a House, Says FDA’s BIMO Director

  • DE&I

    Trust-Building, Community Connection Still Essential to DE&I Efforts, Experts Say

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 703.538.7600 – Toll free 888.838.5578

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing